1. Active Stocks: $ADXS $DXCM $CYTK $VRX $NLNK http://www.talkmarkets.com/content/us-markets/active-stocks-adxs-dxcm-cytk-vrx-nlnk?post=51376

  2. $CYTK Seems to get to resistant levels and cant break through..... Cmon CYTK!!!!

  3. $CYTK be careful with jamesdyer he is an short attempting to throw bogus numbers

  4. Active Stocks: $ADXS $DXCM $CYTK $VRX $NLNK http://www.talkmarkets.com/content/us-markets/active-stocks-adxs-dxcm-cytk-vrx-nlnk?post=51376

  5. $CYTK Paid pumpers on this board. Read the press release carefully. $2/share coming.

  6. $CYTK 3.60 is key level. Was support for a long time, now will be resistance. If we break through there then can regain 4

  7. $CYTK They announceed re-initiation of the Tirasemtiv study to commence in 2015. $13 here we come again baby!!!!

  8. $CYTK This stock as it climbs back up to the 13s. In the next few months we will see this back in the 4-5 range. Then higher thereafter!

  9. $CYTK http://phx.corporate-ir.net/phoenix.zhtml?c=142156&p=IROL-secToc&TOC=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9vdXRsaW5lLnhtbD9yZXBvPXRlbmsmaXBhZ2U9OTg1MTk5NyZzdWJzaWQ9NTc%3d&ListAll=1

  10. $CYTK New Seeking alpha article: http://seekingalpha.com/article/2574985-cytokinetics-is-planning-new-phase-3-trial-for-tirasemtiv-in-als-using-new-endpoint

  11. $CYTK If FDA approves SVC as endpoint, look for a partner and significant upside to follow

  12. @AnalystRatingsNetwork $cytk Roth reiterates buy....but no PT

  13. $CYTK Tirasemtiv Study will continue!!!!!!!!!!!!!!!!

  14. $CYTK http://www.nasdaq.com/press-release/cytokinetics-provides-development-program-update-for-tirasemtiv-20141020-00242

  15. $CYTK effects on SVC could be a Phase III clinical trial endpoint w/ support of tirasemtiv as a potential treatment for patients with ALS

  16. $CYTK CYTK begun regulatory interactions with FDA regarding results from BENEFIT-ALS and has received initial feedback from the FDA.

  17. Cytokinetics s buy rating reiterated at Roth Capital. http://www.analystratings.net/stocks/NASDAQ/CYTK/?RegistrationCode=SocialMedia-direct $CYTK

  18. @BValue @AlertTrade $CYTK $$$$

  19. $CYTK October has historically been a weak month for biotech, with the Biotech Index underperforming the S&P 500 in 14 out the last 20 yrs

  20. $CYTK wow announcement of p3 TIRA didn t have the positive effect I thought it would...only 5% sucks

  21. $CYTK ...and a article out this am aswell ..... http://seekingalpha.com/article/2574985-cytokinetics-is-planning-new-phase-3-trial-for-tirasemtiv-in-als-using-new-endpoint?uprof=45 ...

  22. $CYTK ...More good news... but from another company this am about ...ALS... http://www.businesswire.com/news/home/20141019005074/en/Genervon-Announces-ALS-PD-Phase-2a-Trial#.VEUwv2daxi1 .....

  23. $CYTK hold on.. $4.50-$5.00 expected around Dec..

  24. $CYTK Partnership for Tira would be even better news, but my guess is other companies are on sidelines pending FDA recs on endpoints

  25. $CYTK with good news today. Two pieces of good news in around a week... when was the last time we could say that here?